Related Experiment Video
Updated: Feb 6, 2026

Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders
Published on: April 14, 2017
Generation and characterization of iPSC-derived microglia for in vitro modeling of stimuli-specific neuroimmune
Angela K Haskell1, Joshua A Kulas1, William E Carter1
1Indiana Biosciences Research Institute, Indianapolis, Indiana, USA.
Introduction:
Microglia are macrophage-like brain resident immune cells known to express numerous Alzheimer's disease risk genes. Here we generated a human induced pluripotent stem cell (iPSC) derived microglia cell culture model for use in neuroimmune modeling and therapeutic testing.
Methods:
We generated iPSC lines using episomal reprogramming for subsequent stepwise differentiation of iPSC-derived microglia (iMG) without commercial kits. We characterized the responses of this model to immunogenic stimuli and recombinant TREM2 antibodies.
Results:
The iMG expressed several key microglia signature genes and are morphologically and transcriptionally dynamic. iMG rapidly phagocytosed myelin debris and strongly changed expression of lipid homeostasis genes. iMG expressed TREM2 and increased TREM2 levels in response to IL-4. Recombinant TREM2 antibody treatment impaired iMG myelin phagocytosis and upregulated chemokines.
Discussion:
We validated our iMG model system for the evaluation of biological responses of human microglia-like cells to stimuli and pharmacological agents for their transcriptional and functional impacts.
Insights
Researchers developed a human induced pluripotent stem cell (iPSC)-derived microglia (iMG) model. This model effectively mimics human microglia functions for Alzheimer's disease research and therapeutic testing.
Area of Science:
- Neuroscience
- Immunology
- Stem Cell Biology
Background:
- Microglia, the brain's immune cells, are implicated in Alzheimer's disease (AD) due to their expression of AD risk genes.
- A robust in vitro model of human microglia is crucial for studying neuroinflammation and developing AD therapeutics.
Purpose of the Study:
- To generate and characterize a human induced pluripotent stem cell (iPSC)-derived microglia (iMG) model.
- To validate this iMG model for neuroimmune modeling and therapeutic screening.
Main Methods:
- Human iPSC lines were generated via episomal reprogramming.
- Stepwise differentiation protocols were employed to derive iMG without commercial kits.
- iMG responses to immunogenic stimuli and anti-TREM2 antibodies were characterized.
Main Results:
- iMG expressed key microglia signature genes and exhibited dynamic morphology and transcriptional profiles.
- iMG demonstrated rapid myelin debris phagocytosis and altered lipid homeostasis gene expression.
- TREM2 expression in iMG increased upon IL-4 stimulation; TREM2 antibody treatment impaired phagocytosis and upregulated chemokines.
Conclusions:
- The iPSC-derived microglia (iMG) model provides a validated system for studying human microglia.
- This model enables the evaluation of cellular responses to various stimuli and pharmacological agents.
- The iMG system is suitable for assessing transcriptional and functional impacts in neuroimmune research.
Related Concept Videos
Dose-Response Relationship: Selectivity and Specificity
Responses to Salt Stress
Specific Heat
For example, increasing the temperature of one gram of water by 1°C requires one calorie of heat energy and can be written as 1 cal/g-°C, or...
Humoral Immune Responses
Responses to Drought and Flooding
Cell Specific Gene Expression

